In this article
You’re treating your menopause symptoms. What’s the plan for your heart?
You want the hot flashes to settle. You want to sleep. You may be deciding about hormones or already taking them. At the same time, your cholesterol or blood pressure may be changing. Those questions belong in the same appointment.
Hormone changes can be part of what happens to your heart health in midlife. They do not explain every symptom or result. Relief from hot flashes also cannot tell you whether your blood pressure or cholesterol needs attention.
Start with what has changed, then bring in what came before: pregnancy complications, family history, earlier results, and the medicines you take. Menopause does not mean heart disease is inevitable. It is a chance to make a plan with the whole story in view.
Which hormones are we talking about?
Estrogen and progesterone change through perimenopause and become lower after menopause. This transition can happen alongside changes in LDL cholesterol, how blood vessels work, blood sugar, muscle, and where fat is stored. Hormones are one influence—not the whole explanation—and age, genetics, sleep, medicines, movement, and other health conditions still matter.
If you still have a uterus and use estrogen that works throughout the body, you generally also need enough progesterone or a similar hormone to protect the lining of the uterus. This helps make the treatment safer. It does not prove that progesterone protects the heart.
Testosterone is not a general menopause, heart-protection, weight-loss, or anti-aging treatment. For women after menopause, evidence supports its use only for hypoactive sexual desire disorder—ongoing low sexual desire that causes distress—after a full medical assessment. We do not yet know its long-term safety for heart or breast health.
What can change during perimenopause and menopause?
The menopause transition is more than the day periods stop. It is a stretch of years when ovarian hormone patterns change. Research reviewed by the American Heart Association describes this transition as a time when several cardiovascular risk factors may shift.
Cholesterol can rise even when a woman did not suddenly change how she eats. Blood pressure patterns may change. Blood sugar, sleep, muscle, and where weight settles around the middle can change during the same years. Some women also report new pounding, racing, fluttering, or skipped beats.
A 2026 study of 9,248 U.S. women found that, after accounting for age, women classified as perimenopausal had higher odds of falling into the study’s low overall cardiovascular-health group than women who were still having regular periods. Cholesterol and blood sugar showed the clearest differences. The study found an association; it did not prove that hormone changes caused every difference.
The study compared different women at one point in time. It used what women reported about their periods to decide their menopause stage. Only 205 were in perimenopause. Researchers did not follow women through menopause or measure later heart attacks or strokes.
- Cholesterol: compare older and newer LDL, HDL, triglyceride, and other cholesterol-test results when available.
- Blood pressure: for routine trends, use correctly taken readings over time. Pregnancy and recent childbirth need different guidance; contact your maternity team promptly about a high reading or new symptoms. For other adults, if the top number is higher than 180 or the bottom number is higher than 120 and you have chest pain, shortness of breath, back pain, numbness, weakness, a vision change, or trouble speaking, call 911—do not wait for the pressure to fall. Without those symptoms, wait at least one minute and repeat the reading; if it remains that high, contact a health professional as soon as possible.
- Blood sugar: compare results over time, including A1C, alongside sleep, medicines, activity, and weight changes. A1C reflects average blood sugar over about three months.
- Symptoms: record what a palpitation, breathlessness, or change in exercise tolerance felt like, when it happened, and what came with it.
- Capacity: notice whether stairs, pace, strength, carrying, and recovery are easier, steady, or becoming harder.
Why hormones should not become the automatic answer
A symptom beginning during perimenopause may still have another explanation. Palpitations can be influenced by sleep, caffeine, alcohol, stress, medicines, thyroid problems, anemia, illness, or a heart-rhythm problem. Higher blood pressure can also relate to family history, kidney health, sleep apnea, pain, medicines, salt, alcohol, and other factors.
Ask what else could explain the change and what information would help clarify it. The timing, pattern, accompanying symptoms, and your health history can help your clinician decide whether a test is needed and which question it should answer.
Your timeline may show more than one isolated result
Compare older blood-pressure, cholesterol, triglyceride, and blood-sugar results with the newest ones. Add when periods began changing, when symptoms appeared, and whether medicines, sleep, weight, or activity changed at the same time.
Carry pregnancy history forward too. Preeclampsia, high blood pressure during pregnancy, gestational diabetes, preterm delivery, and having a baby who was small for gestational age can remain useful cardiovascular information years later. These events do not predict one woman’s future by themselves, but they should not disappear from her heart history.
Include family history and any inherited risk results you already have. This timeline can help your clinician decide what to address first and whether another test would change your care.
What does hormone therapy mean for the heart?
Some menopause hormone treatments work throughout the body. These are called systemic treatments and can help with hot flashes and night sweats. Others are used in the vagina for symptoms such as dryness or urinary discomfort. These treatments differ in how much hormone reaches the bloodstream, what they treat, and their risks.
Hormone therapy is not one drug or one decision. The balance of benefits and risks can differ by the exact hormones, dose, route, timing, duration, whether a woman has a uterus, and her personal history.
In February 2026, the FDA approved revised labeling for a first group of six menopause hormone-therapy products. Several risk statements were removed from boxed warnings. That change did not make every product risk-free, make hormone therapy right for every woman, or turn it into a treatment prescribed simply to prevent heart disease.
A hormone-therapy decision belongs with a qualified clinician. Systemic hormone therapy is generally not used with unexplained vaginal bleeding, liver disease, a prior estrogen-sensitive cancer, coronary heart disease, heart attack, stroke or a venous blood clot, or a personal or inherited high risk of blood clots. If any applies, specialist guidance is important. Age and time since menopause, blood pressure, migraine history, medicines, symptoms, and the exact product, dose, and route also shape the decision; those factors are not all automatic exclusions.
Very little estrogen from low-dose vaginal treatment reaches the bloodstream. It is considered separately from hormone treatment that works throughout the body. If you have a history of breast cancer, discuss it with your cancer specialist. Online claims cannot replace a review of your own health and treatment options.
What does the September 2026 hormone study add?
A study published September 8 in JAMA Internal Medicine examined 2,737 women with hot flashes or night sweats. Starting hormone therapy was linked to an estimated 22% lower risk of heart and blood-vessel problems during follow-up.
Researchers compared existing treatment choices. They did not randomly assign women to take hormones. Other differences between the groups could explain some of the finding. The 22% is a relative estimate, not a promised benefit for you.
The authors say this study should not be used to recommend hormones for heart-disease prevention. It adds to the conversation about symptoms, treatment timing, and health history. Blood pressure, cholesterol, and other heart risks still need their own plan.
What should I bring to a midlife heart conversation?
You do not need a perfect record. Bring what you know, leave what you do not, and organize the facts that may change a decision. A short timeline can be more useful than a pile of disconnected pages.
- When periods or menopause symptoms began changing.
- Several recent blood-pressure readings taken with good technique.
- Older and newer cholesterol, triglyceride, blood-sugar, and A1C results when available.
- Pregnancy complications and the approximate year they happened.
- Heart disease or stroke in close relatives, including how old they were when it happened.
- New symptoms, their timing, duration, triggers, and what you felt at the same time.
- Prescription medicines, over-the-counter products, hormones, and supplements.
- Any clear change in stairs, pace, strength, recovery, or the activities you want to keep doing.
The HEART RESERVE takeaway
You deserve help with menopause symptoms and a plan for your heart. Bring your treatment, results, pregnancy and family history, and any change in what your body can do into one conversation.
Your free Heart Story helps you put those details in one summary for your next appointment. Together, you and your clinician can decide what needs attention now and what to follow over time.
Your next step
Bring symptoms and measurements together
Put recent blood pressure readings and lab results beside your symptom timeline and medicine list. Include pregnancy complications and family history so the visit can connect current symptoms with your longer health history.
Before you leave, confirm the next step, when it should happen, and who will follow up.
Free. No account needed. Use your notes with your care team.
Evidence behind the article
Sources and editorial review
Sources last checked:
- Menopausal Hormone Therapy and Cardiovascular Risk in Midlife Women With Vasomotor SymptomsWang, Swanson, Brooks, and colleagues · JAMA Internal Medicine · September 8, 2026
- Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early PreventionAmerican Heart Association · Circulation · 2020
- Cardiovascular Health Characterization Using Life’s Essential 8 Score in Perimenopausal WomenJournal of the American Heart Association · 2026
- The 2022 Hormone Therapy Position Statement of The North American Menopause SocietyThe North American Menopause Society · Menopause · 2022
- FDA Approves Labeling Changes to Menopausal Hormone Therapy ProductsU.S. Food and Drug Administration · 2026
- Palpitations across the menopause transition in SWAN: trajectories, characteristics, and associations with subclinical cardiovascular diseaseMenopause · 2023
- 2025 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in AdultsAmerican Heart Association and American College of Cardiology · 2025
- Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Prevention in WomenAmerican Heart Association · Circulation · 2021
- Symptoms, Diagnosis and Monitoring of ArrhythmiaAmerican Heart Association · 2024
- Global Consensus Position Statement on the Use of Testosterone Therapy for WomenThe Journal of Clinical Endocrinology & Metabolism · 2019
- Preeclampsia and High Blood Pressure During PregnancyAmerican College of Obstetricians and Gynecologists · Current guidance
- When To Call 911 About High Blood PressureAmerican Heart Association · 2025
October 20, 2026: Clarified that the general adult threshold for very high blood pressure does not apply during pregnancy or after childbirth. Those situations need maternity-team guidance and different thresholds.
Independent clinical review is identified only when it has been completed and approved in writing. No external reviewer or organization is implied. Sources do not imply endorsement of HEART RESERVE.
